EGFR amplification is a putative resistance mechanism for NSCLC–LM patients with TKI therapy and is associated with poor outcome
Article in Frontiers in Oncology (August 2022)
The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.
Article in Frontiers in Oncology (August 2022)
Article in Future Medicinal Chemistry (July 2022)
Article in International Journal of Molecular Sciences (June 2022)